| Market revenue in 2025 | USD 478.8 million |
| Market revenue in 2033 | USD 817.4 million |
| Growth rate | 6.9% (CAGR from 2026 to 2033) |
| Largest segment | Immunoassay |
| Fastest growing segment | Molecular Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunoassay, Molecular Diagnostics |
| Key market players worldwide | BD, Roche, Hologic Inc, Abbott Laboratories, Danaher Corp, Qiagen NV, OraSure Technologies Inc, Bio-Rad Laboratories Inc, BioMerieux SA, Thermo Fisher Scientific Inc, Seegene, Diasorin SpA |
The geriatric population in Japan is increasing rapidly, wherein both life expectancy & per capita income in population aged 80 & above are high. Strategies being undertaken for geographic expansion in Asia Pacific by major U.S.-based players to strengthen their position are anticipated to drive market growth in this country.
The market in Japan is expected to grow at a steady rate in the coming years due to varying requirement of tests in Japan, which is mostly based on physicians’ demand for the tests. The Japanese government and regulatory authorities have implemented a framework to encourage collaborations and partnerships.
The Ministry of Japan controls the reimbursement scenario in the country. The country launched a modernized list of reimbursement prices along with the devices and tests that are reimbursed. This updated reimbursement structure aids in providing affordable diagnosis to Japanese population.
Publish Date: Jun 18, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Diasorin SpA | View profile | 3,233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | www.diasoringroup.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | www.roche.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to STD Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Immunoassay was the largest segment with a revenue share of 48.79% in 2025.
Horizon Databook has segmented the Japan std diagnostics market based on immunoassay, molecular diagnostics covering the revenue growth of each sub-segment from 2021 to 2033.
The geriatric population in Japan is increasing rapidly, wherein both life expectancy & per capita income in population aged 80 & above are high. Strategies being undertaken for geographic expansion in Asia Pacific by major U.S.-based players to strengthen their position are anticipated to drive market growth in this country.
The market in Japan is expected to grow at a steady rate in the coming years due to varying requirement of tests in Japan, which is mostly based on physicians’ demand for the tests. The Japanese government and regulatory authorities have implemented a framework to encourage collaborations and partnerships.
The Ministry of Japan controls the reimbursement scenario in the country. The country launched a modernized list of reimbursement prices along with the devices and tests that are reimbursed. This updated reimbursement structure aids in providing affordable diagnosis to Japanese population.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan STD Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan STD Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
